drugset / Trial / NCT01628770

Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia

NCT01628770

Completed 271 enrolled Dow University of Health Sciences
RandomizedParallel-groupOpen-labelPrevention

Summary

The investigators hypothesized that both isomaltoside 1000 (Monofer), and oral iron preparation will be equally effective in correction of postpartum iron deficiency anemia.

Timeline

Start
2012-05
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 200 mg Oral
Subject Iron isomaltoside 1000 Unknown 20 mg/kg Intravenous

Indications

No indication recorded.